Glitches in CoWIN also responsible for low COVID-19 vaccine uptake
On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking the jab, only about two-third of the eligible people were…
A Science and Technology Blog
On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking the jab, only about two-third of the eligible people were…
In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the Indian regulator are safe. The Health Ministry released a statement…
True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…
The phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of Medical Sciences & Research Centre appears to suffer from serious…
The Ahmedabad-based Zydus Cadilla only recently got the regulatory permission to carry out phase-3 trial and has to begin the recruitment, while the Hyderabad-based Biological E is yet to reach…
Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…
As on December 4, U.K has reported 2.7 million cases and over 75,500 deaths, the second highest death toll in Europe. There have been more than 50,000 new SARS-CoV-2 cases…
Transparency in the approval process is vital for gaining the trust of people so that they don’t hesitate to take the vaccine. If there is already some degree of anxiety…